← All comparisons
Head-to-head · FAERS comparison

Alprazolam vs Zolpidem: side effects in FDA adverse event reports

Alprazolam profile · Zolpidem profile · data 2026-09-14
How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

AlprazolamZolpidem
Drug classBenzodiazepine–
Brand names–Zolpidem Tartrate
FAERS reports204,870134,336
Serious71%69%
Death outcome33,44615,992
Boxed warningYes RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids maYes COMPLEX SLEEP BEHAVIORS Complex sleep behaviors including sleep-walking, sleep-driving, and engaging in other activities while not fully awake may occur followi

Signals both drugs share

ReactionAlprazolamZolpidemLabel screen (A / B)
Drug use disorder951 · PRR 13.2555 · PRR 11.2Labeled (related wording) / Labeled (related wording)
Multiple drug overdose intentional312 · PRR 10.7166 · PRR 8.3Labeled (related wording) / Labeled (related wording)
Rebound acid hypersecretion252 · PRR 9.1217 · PRR 11.8Labeled (related wording) / Not in label — unassessed
Sopor2,105 · PRR 19.0670 · PRR 8.2Not in label — unassessed / Not in label — unassessed
Poisoning deliberate1,439 · PRR 18.6410 · PRR 7.2Not in label — unassessed / Not in label — unassessed
Nephrogenic anaemia450 · PRR 10.8460 · PRR 16.9Not in label — unassessed / Not in label — unassessed
Pre-existing condition improved409 · PRR 7.0299 · PRR 7.7Not in label — unassessed / Not in label — unassessed
Hyperparathyroidism secondary242 · PRR 10.7256 · PRR 17.5Not in label — unassessed / Not in label — unassessed
Bradypnoea255 · PRR 10.6114 · PRR 6.9Not in label — unassessed / Not in label — unassessed
Prescription form tampering184 · PRR 32.0142 · PRR 35.2Not in label — unassessed / Not in label — unassessed
Homicide155 · PRR 9.5162 · PRR 15.3Not in label — unassessed / Not in label — unassessed
Chronic kidney disease-mineral and bone disorder132 · PRR 14.2127 · PRR 20.8Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Alprazolam

Labeled signals distinctive to Zolpidem

Common questions

Which has more reported side effects, Alprazolam or Zolpidem?

Alprazolam has 204,870 FAERS reports and Zolpidem 134,336. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (71% vs 69%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Alprazolam and Zolpidem share?

Both drugs carry disproportionality signals for drug use disorder, multiple drug overdose intentional, rebound acid hypersecretion, sopor, poisoning deliberate. Shared signals often reflect a shared drug class or the condition both are used for.

Is Alprazolam or Zolpidem safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.